Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Segovia

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Life Sciences|August 16, 2025
GPR41 and GPR43 modulate rodent pancreatic α-cell function and growthA Sánchez-Roncero, T Fernández-Marcelo, A A Pérez-Serna, et al.
Immunology and Cell Biology|July 23, 2020
Specific macrophage subsets accumulate in human subcutaneous and omental fat depots during obesityAngélica Girón-Ulloa, Erika González-Domínguez, Rebeca S Klimek, et al.
Molecular Biology of the Cell|October 26, 2007
Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signalingCarmen Segrelles, Marta Moral, Corina Lorz, et al.
Frontiers in Cell and Developmental Biology|April 2, 2021
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic EfficacyDavid García-Bernal, Mariano García-Arranz, Rosa M Yáñez, et al.
Journal of Biochemistry|July 29, 2006
Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient miceSergio Acín, María A Navarro, José M Arbonés-Mainar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patientsAriana Jacome, Susana Navarro, Paula Río, et al.
Blood|August 13, 2017
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34<sup>+</sup> cells from Fanconi anemia patientsPaula Río, Susana Navarro, Guillermo Guenechea, et al.
Nature Communications|October 9, 2020
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cellsM Martinez-Lage, R Torres-Ruiz, P Puig-Serra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Safe and Efficient Gene Therapy for Pyruvate Kinase DeficiencyMaria Garcia-Gomez, Andrea Calabria, Maria Garcia-Bravo, et al.
Leukemia|October 27, 2015
Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPαC Bueno, J L Sardina, B Di Stefano, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Life Sciences|August 16, 2025
GPR41 and GPR43 modulate rodent pancreatic α-cell function and growthA Sánchez-Roncero, T Fernández-Marcelo, A A Pérez-Serna, et al.
Immunology and Cell Biology|July 23, 2020
Specific macrophage subsets accumulate in human subcutaneous and omental fat depots during obesityAngélica Girón-Ulloa, Erika González-Domínguez, Rebeca S Klimek, et al.
Molecular Biology of the Cell|October 26, 2007
Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signalingCarmen Segrelles, Marta Moral, Corina Lorz, et al.
Frontiers in Cell and Developmental Biology|April 2, 2021
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic EfficacyDavid García-Bernal, Mariano García-Arranz, Rosa M Yáñez, et al.
Journal of Biochemistry|July 29, 2006
Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient miceSergio Acín, María A Navarro, José M Arbonés-Mainar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patientsAriana Jacome, Susana Navarro, Paula Río, et al.
Blood|August 13, 2017
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34<sup>+</sup> cells from Fanconi anemia patientsPaula Río, Susana Navarro, Guillermo Guenechea, et al.
Nature Communications|October 9, 2020
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cellsM Martinez-Lage, R Torres-Ruiz, P Puig-Serra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Safe and Efficient Gene Therapy for Pyruvate Kinase DeficiencyMaria Garcia-Gomez, Andrea Calabria, Maria Garcia-Bravo, et al.
Leukemia|October 27, 2015
Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPαC Bueno, J L Sardina, B Di Stefano, et al.
Pageof 11